GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (LTS:0JDM) » Definitions » E10

IQVIA Holdings (LTS:0JDM) E10 : $4.18 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is IQVIA Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

IQVIA Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was $1.560. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $4.18 for the trailing ten years ended in Mar. 2024.

During the past 12 months, IQVIA Holdings's average E10 Growth Rate was 16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-20), IQVIA Holdings's current stock price is $231.895. IQVIA Holdings's E10 for the quarter that ended in Mar. 2024 was $4.18. IQVIA Holdings's Shiller PE Ratio of today is 55.48.

During the past 13 years, the highest Shiller PE Ratio of IQVIA Holdings was 102.59. The lowest was 46.38. And the median was 63.28.


IQVIA Holdings E10 Historical Data

The historical data trend for IQVIA Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings E10 Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.87 3.39 4.03

IQVIA Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.56 3.72 3.94 4.03 4.18

Competitive Comparison of IQVIA Holdings's E10

For the Diagnostics & Research subindustry, IQVIA Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Shiller PE Ratio falls into.



IQVIA Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IQVIA Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.56/131.7762*131.7762
=1.560

Current CPI (Mar. 2024) = 131.7762.

IQVIA Holdings Quarterly Data

per share eps CPI Adj_EPS
201406 0.640 100.560 0.839
201409 0.710 100.428 0.932
201412 0.690 99.070 0.918
201503 0.680 99.621 0.899
201506 0.670 100.684 0.877
201509 0.890 100.392 1.168
201512 0.850 99.792 1.122
201603 0.880 100.470 1.154
201606 0.710 101.688 0.920
201609 0.820 101.861 1.061
201612 -0.740 101.863 -0.957
201703 0.430 102.862 0.551
201706 0.280 103.349 0.357
201709 0.400 104.136 0.506
201712 5.020 104.011 6.360
201803 0.320 105.290 0.400
201806 0.290 106.317 0.359
201809 0.290 106.507 0.359
201812 0.340 105.998 0.423
201903 0.290 107.251 0.356
201906 0.300 108.070 0.366
201909 0.290 108.329 0.353
201912 0.090 108.420 0.109
202003 0.420 108.902 0.508
202006 -0.120 108.767 -0.145
202009 0.520 109.815 0.624
202012 0.610 109.897 0.731
202103 1.090 111.754 1.285
202106 0.900 114.631 1.035
202109 1.340 115.734 1.526
202112 1.630 117.630 1.826
202203 1.680 121.301 1.825
202206 1.340 125.017 1.412
202209 1.490 125.227 1.568
202212 1.200 125.222 1.263
202303 1.530 127.348 1.583
202306 1.590 128.729 1.628
202309 1.630 129.860 1.654
202312 2.540 129.419 2.586
202403 1.560 131.776 1.560

Add all the adjusted EPS together and divide 10 will get our e10.


IQVIA Holdings  (LTS:0JDM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

IQVIA Holdings's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=231.895/4.18
=55.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of IQVIA Holdings was 102.59. The lowest was 46.38. And the median was 63.28.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


IQVIA Holdings E10 Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings (LTS:0JDM) Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (LTS:0JDM) Headlines

No Headlines